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EditorialCredibility and ReproducibilityCredibility is everything for science, and it is built over time in
both obvious and subtle ways. It is how we interact with col-
leagues and collaborators. It is how generously and openly we
share reagents and how we mentor students and postdocs. It
is how we review each other’s papers, and it is how we credit
others’ work. It is the way we educate and inform the public
that funds us. It is the way we document and store our data.
And it is the rigor, transparency, and attention we invest in
designing, conducting, and reporting experiments. Without
credibility, others can’t/won’t build on our work, and as a result,
the pace of scientific advance is slowed. Most importantly, sci-
ence contaminated with a lack of credibility is a housewith crum-
bling walls that engenders little trust and provides minimal value
to our global society, present and future.
But everyone reading this already knows the importance of
credibility in science, so why are we discussing it here? Within
the last 12 months the reproducibility of science, a lynchpin of
credibility, has come under intense scrutiny, both from the NIH
(Nature 505, 612–613) and other government funding bodies,
as well as in the lay (The Economist, October19, 2013, 23–28)
and scientific press (Nature 483, 531–533—though many of
these reports themselves would benefit from greater transpar-
ency in reporting and still require robust demonstrations of
reproducibility). Hearing the word ‘‘reproducibility,’’ most of us
think immediately of fraud or data and image manipulation, but
it is much broader than that. Many of the current concerns about
reproducibility, particularly the successful scalability of preclini-
cal data into robust drug targets for treating human disease, are
focused on the rigor of the experimental design (inclusion of all
appropriate controls, blinded experimental conditions, gender
balance in experimental populations, a priori determination of
n’s and statistical power, appropriate statistical analyses, etc.)
and on complete transparency in reporting of these parameters
and all collected data (for a recent Perspective on this topic, see
Neuron 84, 572–581.)
In June of this year Francis Collins, NIH Director, Marcia
McNutt, Editor-in-Chief of Science, and Philip Campbell, Edi-
tor-in-Chief of Nature, organized a meeting of journal editors
and other contributors to collaborate on approaches to ensuring
and improving reproducibility. Maximizing reproducibility clearly
is an initiative involving many stakeholders, with scientists front
and center and funding bodies, universities, journals, pharma-
ceutical and biotech companies, patient advocacy groups, and
society at large all taking a leading role as well. Out of the discus-
sions at this meeting came a set of recommendations for how
journals and journal editors can do their part. The main focus
of the guidelines is to ensure rigorous experimental design and
transparency in reporting the specifics about how experiments
were performed and how data were collected and analyzed.
Cell Press participated in the meeting and is a signatory on the
recommendations that were recently posted (http://www.nih.
gov/about/reporting-preclinical-research.htm). Many of the
items in the guidelines Cell and its sister journals are alreadydoing and have been doing for quite some time (providing space
for lengthymethods sections in print and unlimited supplemental
methods online, requiring the sharing of reagents as a condition
of publication, providing a forum for refutation in our Matters
Arising format, requiring authors to clearly state their statistical
measures.) Other items in the guidelines, like developing a way
to facilitate clear reporting in the paper of details about how ex-
periments were designed and performed, will be valuable addi-
tions to what we already do. Journals are encouraged to adopt
a checklist of specific reporting criteria as a standard form for au-
thors to complete and editors and/or reviewers to verify. While
we at Cell and the other Cell Press journals are not yet sure
that an author checklist per se will be the most effective imple-
mentation for our authors, reviewers, and readers, we do wholly
embrace the importance of the goals of the guidelines andwill be
taking steps to adapt our editorial processes and author instruc-
tions to ensure consistent standards for appropriate experi-
mental design and transparency in reporting. For example,
Developmental Cell has recently introduced supplemental proto-
cols, where authors of a paper with noteworthy, new, or particu-
larly challenging methods are encouraged to provide a detailed
protocol in a separate supplemental PDF. We view these steps
as an important part of the value that we add through the editorial
and peer review process.
Enhanced attention to these elements will also help protect the
authors’ credibility. With increased clarity about how experi-
ments were performed and collected, editors, authors, and re-
viewers will all be better able to spot and rectify concerns before
the paper is published, hopefully reducing the number of correc-
tions and retractions required postpublication. To this end, Cell
and our sister journals are also introducing an image screening
process to help ensure adherence to community standards as
outlined in our data processing policies. More and more, we
are finding that the concerns that arise regarding published
data are often the result of avoidable errors. For example,
copying and pasting the same image into two different figures
or failing to indicate where lanes of a gel have been spliced
together. (Oddly, the most pervasive challenges to published
data we see at Cell relate to loading controls. There seems to
be some misalignment among scientists regarding the impor-
tance and meaning of the actin bands in a standard western
blot.) When potential problems are brought to our attention by
a concerned reader, we ask the authors to provide us with the
original unprocessed data, together with a detailed explanation
of how they conducted the experiment. Most of the time, we
can see from the raw data that the problems have been intro-
duced through simple mistakes and can be addressed with an
erratum. But a scientific literature peppered with corrections
does not build credibility, and worse still is when the avoidable
errors are sufficiently extensive that they undermine the reliability
of the entire body of work and necessitate a retraction. So, as we
at Cell invest in checking figures and working with authors to fix
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that authors renew their focus on preparing their manuscripts
and reviewing the final figures with the same attentive eyes their
readers will. By combining enhanced clarity of reporting as rec-
ommended by the new guidelines with prepublication image
screening, our intent is to ensure that every paper we publish
meets not only the highest standards of interest and importance
but also of credibility and reproducibility.966 Cell 159, November 20, 2014 ª2014 Elsevier Inc.With increased vigilance from authors, funders, and journals
and attention to standards for experimental design and accurate
careful reporting, wewill collectively increase the public trust and
support for research and build a stronger pipeline for converting
our understanding of the basic processes and mechanisms of
biology into improved diagnostics, treatments, and potentially
cures for the myriad of global health challenges.Emilie Marcus
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